nocodazole and ilmofosine

nocodazole has been researched along with ilmofosine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grunicke, H; Hofmann, J; Jackman, J; Kohn, KW; O'Connor, PM; Schubert, C; Ueberall, F1

Other Studies

1 other study(ies) available for nocodazole and ilmofosine

ArticleYear
The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents.
    Biochemical and biophysical research communications, 1994, Mar-15, Volume: 199, Issue:2

    Topics: Alkaloids; Antineoplastic Agents; Burkitt Lymphoma; CDC2 Protein Kinase; Cell Cycle; Cell Line; DNA Damage; Dose-Response Relationship, Radiation; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; G2 Phase; Humans; Kinetics; Mechlorethamine; Nocodazole; Phospholipid Ethers; Protein Kinase C; Radiation, Ionizing; Staurosporine; Tumor Cells, Cultured

1994